7.54
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LFMD Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$7.25
Aprire:
$7.235
Volume 24 ore:
1.11M
Relative Volume:
0.71
Capitalizzazione di mercato:
$271.96M
Reddito:
$193.06M
Utile/perdita netta:
$-22.51M
Rapporto P/E:
-11.78
EPS:
-0.64
Flusso di cassa netto:
$10.63M
1 W Prestazione:
+23.61%
1M Prestazione:
+46.12%
6M Prestazione:
+69.06%
1 anno Prestazione:
-39.73%
Lifemd Inc Stock (LFMD) Company Profile
Nome
Lifemd Inc
Settore
Industria
Telefono
(866) 351-5907
Indirizzo
236 FIFTH AVENUE, NEW YORK
Confronta LFMD con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LFMD
Lifemd Inc
|
7.54 | 271.96M | 193.06M | -22.51M | 10.63M | -0.64 |
![]()
VEEV
Veeva Systems Inc
|
236.99 | 36.73B | 2.75B | 714.14M | 1.09B | 4.33 |
![]()
DOCS
Doximity Inc
|
59.39 | 10.64B | 516.85M | 174.11M | 217.38M | 0.87 |
![]()
TEM
Tempus Ai Inc
|
54.07 | 9.30B | 640.44M | -743.28M | -206.93M | -11.29 |
![]()
HQY
Healthequity Inc
|
91.42 | 7.43B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
40.98 | 6.34B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-12-10 | Iniziato | Lake Street | Buy |
2024-12-04 | Iniziato | Mizuho | Neutral |
2024-08-23 | Ripresa | B. Riley Securities | Buy |
2024-06-05 | Iniziato | KeyBanc Capital Markets | Overweight |
2023-11-30 | Iniziato | Craig Hallum | Buy |
2023-07-21 | Iniziato | Cantor Fitzgerald | Overweight |
2023-07-03 | Iniziato | H.C. Wainwright | Buy |
2022-03-10 | Iniziato | Colliers Securities | Buy |
2021-10-04 | Ripresa | B. Riley Securities | Buy |
Mostra tutto
Lifemd Inc Borsa (LFMD) Ultime notizie
LifeMD Inc (LFMD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus
Have LifeMD Insiders Been Selling Stock? - simplywall.st
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk's Plan To Sell Wegovy Via Telehealth Operators - MSN
LifeMD (LFMD) to Announce Q1 2025 Earnings and Host Conference C - GuruFocus
LifeMD (LFMD) Enhances Access to Wegovy with NovoCare Partnershi - GuruFocus
Novo Nordisk partners with Hims & Hers, Ro, LifeMD to offer discounted Wegovy - eMarketer
LifeMD expands access to weight management drug Wegovy - Investing.com
Why Hims & Hers Health and LifeMD Are Skyrocketing Today - Mitrade
Novo Nordisk partners with Ro, Hims and LifeMD to sell low-cost Wegovy - The Hill
LifeMD Stock Pops As Company Expands Weight-Loss Offerings With Wegovy - Benzinga
Wegovy to be sold on Hims, Ro and LifeMD for reduced price - Yahoo
Hims & Hers, LifeMD Stocks Surge On Novo Nordisk’s Plan To Sell Wegovy Via Telehealth Operators By Stocktwits - Investing.com India
LifeMD and Hims & Hers Health shares surge on Novo Nordisk partnerships - Investing.com
LifeMD (LFMD) Expands Access to Wegovy with NovoCare Partnership - GuruFocus
LifeMD Expands Access to Weight-Loss Drug Wegovy; Shares Surge - marketscreener.com
LifeMD Shares Surge on Expanded Access to Wegovy - MarketWatch
LifeMD Announces Plans to Expand Affordable Access to Wegovy® fo - GuruFocus
LifeMD Announces Plans to Expand Affordable Access to Wegovy® for Cash-Pay Patients - The Manila Times
LifeMD Makes Wegovy More Affordable: New $499 Monthly Program Includes Home Delivery - Stock Titan
LifeMD buys key assets from Optimal Human Health MD - MSN
LifeMD, Inc. (NASDAQ:LFMD) Receives $11.00 Average Price Target from Brokerages - Defense World
LifeMD to Report First Quarter 2025 Financial Results on May 6 - GlobeNewswire
LifeMD to Report First Quarter 2025 Financial Results on May 6 | - GuruFocus
LifeMD, Inc. to Report Q1 2025 Financial Results on May 6, 2025 - Nasdaq
LifeMD Acquires Women’s Health Provider Optimal Human - GlobeNewswire
Medifast Reports Steep 34% Revenue Drop: Health Coach Network Shrinks as Company Battles Headwinds - Stock Titan
LifeMD Expands Into Women's Health With Acquisition Of Optimal Human Health MD Assets - Nasdaq
LifeMD Acquires Optimal Human Health To Launch Virtual Women's Health Platform In Summer 2025 - Nasdaq
LifeMD (LFMD) Expands into Women's Health with Acquisition - GuruFocus
LifeMD Acquires Optimal Human Health MD - citybiz
LifeMD (LFMD) Expands into Women's Health with Strategic Acquisi - GuruFocus
LifeMD Targets $70B Women's Health Market with Game-Changing Virtual Care Platform - Stock Titan
Geode Capital Management LLC Has $4.07 Million Holdings in LifeMD, Inc. (NASDAQ:LFMD) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
LifeMD appoints CBIZ CPAs as new accounting firm By Investing.com - Investing.com South Africa
LifeMD appoints CBIZ CPAs as new accounting firm - Investing.com Australia
LifeMD Inc (LFMD)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - DWinneX
Is LifeMD Inc (LFMD) positioned for future growth? - Sete News
LifeMD (NASDAQ:LFMD) shareholder returns have been fantastic, earning 316% in 5 years - simplywall.st
(LFMD) Trading Report - news.stocktradersdaily.com
Results from LifeMD Inc (LFMD) show potential - uspostnews.com
LifeMD, Inc. (LFMD): A Bull Case Theory - MSN
LifeMD expands acceptance of insurance to Medicare beneficiaries - TipRanks
LifeMD to Accept Medicare Beneficiaries for Qualifying Virtual Primary Care - marketscreener.com
LifeMD expands Medicare coverage for virtual care - Investing.com
LifeMD expands Medicare coverage for virtual care By Investing.com - Investing.com India
LifeMD (LFMD) Expands Medicare Coverage for Virtual Healthcare Services | LFMD Stock News - GuruFocus
LifeMD Expands Insurance Acceptance to Medicare Beneficiaries for Qualifying Virtual Primary Care, Including in its Weight Loss Programs - The Manila Times
LifeMD Targets 60M Medicare Patients With New Virtual Care Coverage, Weight Loss Programs - Stock Titan
Stocks in play: Rua Gold Inc - The Globe and Mail
Medifast Q1 2025 Earnings Coming April 28: CEO to Detail OPTAVIA Performance - Stock Titan
Lifemd Inc Azioni (LFMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):